// App-Quantinova.ai

e15047 : Neoadjuvant chemotherapy with XELOX regimen for locally advanced operable colon cancer patients: a prospective phase II trial (NCT02415829).

Researchers

Presenter

  • Li Yang

Principal Investigators

  • Fangqi Liu

  • Dan Huang

  • Junyan Xu

  • Lei Huang

  • Ye Xu

Medical Centers

  • Fudan University Shanghai Cancer Center, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Capecitabine

  • Oxaliplatin

  • Capecitabine and oxaliplatin

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved